Sangamo BioSciences | SGMO - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Alaunos Therapeutics USD 400K 213K 2026-03
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Amgen USD 2.86B 16.65B 2026-06
Bayer EUR 6.39B 192M 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
Biogen USD 403.9M 45.4M 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Cipla INR 32.3B 1.95B 2026-03
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.53M 173K 2026-03
CSL USD 3.17B 290M 2025-12
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Grifols EUR 987.75M 47.87M 2025-12
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
J&J USD 9.22B 1.24B 2026-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Merck USD 3.83B 36M 2026-06
Novartis USD 4.26B 64M 2026-06
Omeros USD 8.84M 4.42M 2025-06
Pfizer USD 4.58B 75M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 23.6B 888M 2026-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06